For example, APOBEC3B was found to express higher in patients with improved survival in clear cell ovarian cancer (CCOC), which was also expected to be a promising biomarker for forecasting the effect to platinum-based therapy (57–59). The gene discussed is APOBEC3B; the disease is ovarian clear cell cancer.